Investor Presentaiton

MANAGEMENT'S STRATEGY - GOOD MEDICINE IS STILL GOOD BUSINESS Strategy 1 Grow existing business and margin 2 Strategic acquisitions Drivers of strategy Drive organic growth Accelerate use of teleradiology, digital and AI Drive our ESG strategy Nurture and develop culture and leadership Integrate recent acquisitions. No further acquisitions contemplated at this time . . Consistent with our values that 'patients are at the heart of everything we do', the Company has remained committed to maintaining our workforce and infrastructure to ensure we are well positioned to service patients as demand increases Underlying fundamentals of the radiology industry remain strong and the Company is confident that patient volumes and historical growth patterns will over time return to pre-COVID-19 levels FY23 focus is on organic growth, integrating recent strategic acquisitions and select brownfield and greenfield opportunities In the absence of unforeseen, extraordinary circumstances, 2H FY23 is expected to be materially stronger than 1H FY23 • FY23 replacement and growth capex is expected to be between $30.0m to $35.0m idx

View entire presentation